| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2008 | US20080091020 Polymorphic forms of ziprasidone HCI and processes for their preparation |
| 04/17/2008 | US20080091019 Crystalline form having X-Ray powder diffraction pattern with peaks at 9.4, 13.7, 14.5, 14.9, 18.1, 20.2, 22.8+-0.2 degrees 2 theta; reacting salt of ziprasidone with alkaline agent and precipitating |
| 04/17/2008 | US20080091018 Polymorphic form B2 of ziprasidone base |
| 04/17/2008 | US20080091017 Polymorphic form B2 of ziprasidone base |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080091006 Nitrate ester cyclodextrin complexes |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090916 2-Amino-4-[(1S,2R)-2-(2,5-dimethoxyphenyl)-2-hydroxy-1-methyl-ethylcarbamoyl]butyric acid, aka gamma-L-glutamyl-1R,2S-methoxamine; prodrug of 1R,2S-methoxamine that is converted within the kidney tubules into its active form; transdermal administration; coupling methoxamine with glutamic acid alcohol |
| 04/17/2008 | US20080090915 Method for preventing or attenuating anthracycline-induced cardiotoxicity |
| 04/17/2008 | US20080090914 Staining Composition For Staining An Ophthalmic Membrane |
| 04/17/2008 | US20080090913 Sphingolipid-Derived Phamaceutical Compositions |
| 04/17/2008 | US20080090912 Compositions containing prodrugs of florfenicol and methods of use |
| 04/17/2008 | US20080090911 Storage stability; ethyl laurate and guar gum; alcohol free; topical administration; sexual disorders |
| 04/17/2008 | US20080090910 Methods for treatment of nocturia |
| 04/17/2008 | US20080090909 negative regulator of cell growth factor receptor; pelorol (benzo(a)fluorene) related compounds from marine sponge species; antiinflammatory, antitumor agent, immunostimulant; control gene expression, differentiation, metabolism, phospholipid signaling pathway, signal tansduction |
| 04/17/2008 | US20080090908 Transformating growth factors; mucor/borage oils; multiple sclerosis |
| 04/17/2008 | US20080090907 Crystal Comprising (2R)-2-Propyloctanoic Acid and Amine |
| 04/17/2008 | US20080090906 Dietetics; cancer |
| 04/17/2008 | US20080090905 Antidiabetic agents; insulin resistance; dyslipidemias; dietetics |
| 04/17/2008 | US20080090904 S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer |
| 04/17/2008 | US20080090903 Improved stability via dibasic calcium phosphate dihydrate excipient; tablets; nervous system disorders |
| 04/17/2008 | US20080090902 Improved stability via dibasic calcium phosphate dihydrate excipient; tablets; nervous system disorders |
| 04/17/2008 | US20080090901 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-chagas chemoprophylactic and therapeutical activities |
| 04/17/2008 | US20080090900 Antibiotic bushrin |
| 04/17/2008 | US20080090899 Application of water and organic solvent soluble ivermectin for topical and oral use |
| 04/17/2008 | US20080090898 Boosting immunity |
| 04/17/2008 | US20080090897 Neurodegenerative diseases such as Alzheimer's Disease, multiple sclerosis, Huntington's Disease, or Parkinson's Disease, AIDS related dementia, Amyotrophic Lateral Sclerosis; use of compounds derived from a 4,4,8-trimethyl-17-furanylsteroid skeleton, tetranortriterpenoids |
| 04/17/2008 | US20080090896 Strontium-Based Treatment Of Otosclerosis |
| 04/17/2008 | US20080090895 Novel Pharmaceutical Composition And Their Uses Thereof For Controlling The Different Forms Of Addiction To Drugs |
| 04/17/2008 | US20080090894 Transdermal migraine therapy |
| 04/17/2008 | US20080090893 Use of indoline derivatives such as silodosin to prevent transition to surgical therapy of benign prostatic hyperplasia |
| 04/17/2008 | US20080090892 Amorphous asenapine and processes for preparing same |
| 04/17/2008 | US20080090891 Administering calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 04/17/2008 | US20080090890 Substituted, bicyclic 8-pyrrolidinobenzimidazoles, methods for their production and their use as medicaments |
| 04/17/2008 | US20080090889 Substituted 2-aminoalkylthiobenzimidazole compounds, pharmaceutical compositions thereof and methods for their use |
| 04/17/2008 | US20080090888 Methods and materials for assessing prostate cancer therapies and compounds |
| 04/17/2008 | US20080090887 Triazole compounds that modulate HSP90 activity |
| 04/17/2008 | US20080090885 Combining water, potassium permanganate, and polar inert organic solvent to form first reaction mixture, filtering, adding losartan to form second reaction mixture, adding formaldehyde to second reaction mixture to form precipitate,filtering, acidifying to form precipitate of losartan 5-carboxylic acid |
| 04/17/2008 | US20080090884 Antimicrobial [3.1.0] bicyclohexylphenyl- oxazolidinone derivatives and analogues |
| 04/17/2008 | US20080090883 Hormone-dependent cancers such as breast cancer or prostate cancer; 4-aryl or heteroaryl-substituted 3,3-dioxo-3-thia-4-azatricyclo[5.2.1.02,6]dec-8-ene |
| 04/17/2008 | US20080090882 Heterocyclic Carbonyl Compounds |
| 04/17/2008 | US20080090881 Treatment of diabetes with thiazolidinedione and metformin |
| 04/17/2008 | US20080090880 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators |
| 04/17/2008 | US20080090879 Method of treatment |
| 04/17/2008 | US20080090878 Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders |
| 04/17/2008 | US20080090877 Sulfone impurity can be removed using amine salts of 2-[(4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole when manufacturing the drug pariprazole |
| 04/17/2008 | US20080090876 Diacylglycerol o-acyltransferase (DGAT); treating obesity; for example 2-(2,6-diisopropyl-4-methylphenylaminocarbonyl)-3,6-dipentyl-3,6-dihydro-2H-thiopyran |
| 04/17/2008 | US20080090875 Analgesics, antipyretics, antiinflammatory agents; 4-(4-chlorophenyl)-5-(4-methanesulfonylphenyl)-1,2-dihydropyrazole-3-thione for example; cyclooxygenase-2 (COX-2) inhibitors; side effect reduction |
| 04/17/2008 | US20080090874 Treatment of breakthrough pain in patients suffering from chronic low back pain |
| 04/17/2008 | US20080090873 Sulfonamide derivatives |
| 04/17/2008 | US20080090872 AMPA and NMDA receptor modulators; depression, epilepsy, schizophrenia, Alzheimer's, disease, learning and memory disorders, and mild cognitive impairment; 5,1',5'-trimethyl-2'-phenyl-1',2'-dihydro-2H-[3,4']bipyrazolyl-3'-one for example |
| 04/17/2008 | US20080090871 Cannabimimetic indole derivatives |
| 04/17/2008 | US20080090870 Use of 2-(amino-substituted piperidin-1-yl)benzimidazoles as antidiabetic agents, or to treat carbohydrate and lipid metabolic disorders; use in combination with other drugs; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-yl]-benzenesulfonamide or salts for example |
| 04/17/2008 | US20080090869 Antidiabetic agents, carbohydrate and lipid metabolic disorders; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-y]-benzamide trifluoroacetic acid salt for example; use in combination with other drugs |
| 04/17/2008 | US20080090868 Antidiabetic agents; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-(4-Chlorobenzyl)-2-(3-aminopiperidin-1-yl)-1-(4-fluorobenzyl)-1H-benzimidazole-6-carboxamide hydrochloride for example; use in combination with other antidiabetic, antilipemic agents |
| 04/17/2008 | US20080090867 Azole derivatives in the form of lipase and phospholipase inhibitors |
| 04/17/2008 | US20080090866 Cosmetic Use of Piperidine Derivatives |
| 04/17/2008 | US20080090865 Non-insulin dependent diabetes; agonists of G-protein coupled receptor 40 (GPR40); for example, 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline |
| 04/17/2008 | US20080090864 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 04/17/2008 | US20080090863 Melanin Concentrating Hormone (MCH) receptor antagonists; eating disorder, obesity, psychological disorders, drug addiction, diabetes, cardiovascular disorders; 2-(cyclohexyl(alkyl)amino)pyridines such as 3-chloro-4-fluoro-N-(cis-4-[(4-methoxypyridin-2-yl)amino]cyclohexyl)benzamide |
| 04/17/2008 | US20080090862 Isoquinoline Derivatives as Calpain Inhibitors |
| 04/17/2008 | US20080090861 Cancer and fibrotic disorders such as scarring prevention; 2-(4-methyl-1-(6-methylpyridin-2-yl)-1H-pyrazol-5-yl)thieno[2,3-c]pyridine for example; activin receptor-like kinase-5 (ALK-5) inhibitors |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090859 For example, N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl) ethyl]-2,2-diphenylacetamide; for the diagnosis, prophylaxis and or the treatment of neuropathy, the clinical pictures and symptoms associated therewith, and related disorders |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090857 Statin derivatives |
| 04/17/2008 | US20080090856 useful for the modulation of kinase activity of C-Abl, c-Kit, VEGFR, PDGFR, Flt-3, c-MET, HER family, Raf kinase family and disease polymorphs thereof; hyperproliferative diseases, cancer; 1-(5-(4-(1H-pyrazol-4-yl)pyrimidin-2-yloxy)-2-fluorophenyl)-3-(3-isopropyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)urea |
| 04/17/2008 | US20080090855 Substituted Cyclic Urea Derivatives and the Use Thereof as Vanilloid Receptor 1 Modulators |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090853 Methyl 2-[4-({[2-[2-(2,3-difluorophenyl)ethyl]-4-oxo-1(4H)-quinazolinyl]acetyl}-{[4'-(trifluoromethyl)-4-biphenylyl]methyl}amino)-1-piperidinyl]-2-methylpropanoate, or a salt thereof; preventing or treating diseases such as atherosclerosis, diabetes, rheumatoid arthritis, stroke, inflammation |
| 04/17/2008 | US20080090852 Bicyclic Heteroaromatic Compounds |
| 04/17/2008 | US20080090851 Bicyclic Heteroaromatic Compounds |
| 04/17/2008 | US20080090850 Herpetic neuralgia topical treatment |
| 04/17/2008 | US20080090849 Protein kinase inhibitors, in particular inhibitory properties for CIV1 protein; N2-(4-aminocyclohexyl)-N6-(2-aminoethyl)-1H-purine-2,6-diamine trihydrochloride; fungal diseases such as candidiases, aspergilloses, histoplasmoses and coccidoidoses; fungicidal infections |
| 04/17/2008 | US20080090848 Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides |
| 04/17/2008 | US20080090847 Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090845 Haloalkyl-substituted pyrimidinone derivatives |
| 04/17/2008 | US20080090844 Infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus; Immunomodulators; antiviral and antitumor agents; modulation of cytokine receptors; improved oral tolerability |
| 04/17/2008 | US20080090843 Pharmaceutical formulation for treatment of HBV infection comprising a compound that inhibits the activity of a Src kinase in an amount effective to inhibit HBV replication and a pharmaceutically acceptable carrier |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090841 pyrazinoylguanidine derivatives; more potent, more specific, and/or absorbed less rapidly from mucosal surfaces, and/or are less reversible, give a prolonged pharmacodynamic half-life; treating anthrax, chronic bronchitis, cystic fibrosis,chronic obstructive pulmonary disease, emphysema, pneumonia |
| 04/17/2008 | US20080090840 Heterocyclic GPR40 Modulators |
| 04/17/2008 | US20080090839 Phenoxymethylalkyne inhibitors of lta4h for treating inflammation |
| 04/17/2008 | US20080090838 N-Hydroxyamide Derivatives and Use Thereof |
| 04/17/2008 | US20080090837 Biaryls useful as modulators of ion channels |
| 04/17/2008 | US20080090836 Pyrazole Compounds Useful In The Treatment Of Inflammation |
| 04/17/2008 | US20080090835 Polymorphic forms of ziprasidone HCl and processes for their preparation |
| 04/17/2008 | US20080090834 Selective azole pde10a inhibitor compounds |
| 04/17/2008 | US20080090833 Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form alpha |
| 04/17/2008 | US20080090832 Treating a subject with disorders involving amino acid metabolism, in particular, hyperphenylalaninemia, by administering a therapeutically effective amount of tetrahydrobiopterin (BH4) or salt thereof, wherein the BH4 is administered orally once per day; alleviates dietary restrictions |
| 04/17/2008 | US20080090831 Cytotoxic agents |
| 04/17/2008 | US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090828 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide |
| 04/17/2008 | US20080090827 Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure |
| 04/17/2008 | US20080090826 Muscarinic modulators |
| 04/17/2008 | US20080090825 Metallo-beta-lactamase inhibitors |
| 04/17/2008 | US20080090824 Novel crystalline form of linezolid |
| 04/17/2008 | US20080090823 Thiadiazoles as cxc- and cc- chemokine receptor ligands |